TurboGen (TRBG), which is also traded on the Tel Aviv Stock Exchange (TASE) under the ticker TURB, announced a significant agreement on October 5, 2026. The Petah Tikva-based company, which focuses on developing advanced combined heat and power systems based on multi-fuel microturbine technology, signed a long-term agreement.
The agreement was signed with a leading engineering and manufacturing services provider to advance the development and serial production of the company's proprietary 20-kilowatt systems.
The manufacturer with which TurboGen signed the long-term agreement is based in the European Union and is described as a leading engineering and manufacturing company in its field. The move is intended to directly expand TurboGen's operations in two key markets: the defense market and the civilian market.
According to the Petah Tikva-based company's report, the initial term of the agreement with the European manufacturer is five years. Beyond this initial period, the agreement also includes an automatic renewal mechanism intended to support ongoing commercial production of the systems after all required development stages have been completed.

Yaron Gilboa, CEO of TurboGen, commented on the company's new agreement, saying: "This collaboration is a milestone marking the transition from prototype development to serial production, together with a top-tier global design and manufacturing company based in the European Union."
The CEO's remarks underscore the strategic importance of the collaboration with the European Union engineering and manufacturing company, which is expected to enable the company to advance to the next stage in its product's life cycle, beyond the initial prototype stage.
Gilboa added regarding the next stages of the joint project: "Upon completion of the development phase, we expect our compact 20-kilowatt systems to be ready for commercialization." The company's proprietary systems, which are intended for combined heat and power generation using multi-fuel microturbines, are expected to reach full commercialization immediately after their development is completed under the long-term agreement signed with the leading manufacturer.
Concluding his remarks, TurboGen's CEO addressed the commercial goals, saying: "The agreement is also intended to support sales of the product for defense and civilian projects, and it provides further evidence of TurboGen's commitment to rapidly advancing toward serial production and revenue generation." The company thus summarized its objectives under the agreement, which include expansion into the defense and civilian markets, progress toward ongoing commercial production, and realizing the potential for revenue generation.










